Seres Therapeutics (MCRB) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free MCRB Stock Alerts $0.63 -0.01 (-1.57%) (As of 04/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Mar. 5) -$0.32 Beat By $0.08 Consensus EPS (Mar. 5) -$0.40 Get Seres Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for MCRB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMCRB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MCRB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Seres Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.37)($0.37)($0.37)Q2 20241($0.36)($0.36)($0.36)Q3 20241($0.35)($0.35)($0.35)Q4 20241($0.34)($0.34)($0.34)FY 20244($1.42)($1.42)($1.42)MCRB Earnings Date and InformationSeres Therapeutics last issued its quarterly earnings data on March 5th, 2024. The biotechnology company reported ($0.32) EPS for the quarter, topping analysts' consensus estimates of ($0.40) by $0.08. The company earned $0.06 million during the quarter, compared to the consensus estimate of $0.50 million. Seres Therapeutics has generated ($0.90) earnings per share over the last year (($0.90) diluted earnings per share). Earnings for Seres Therapeutics are expected to grow in the coming year, from ($1.15) to ($0.84) per share. Seres Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Seres Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 3/5/2024Q4 2023($0.40)($0.32)+$0.08($0.32)$0.50 million$0.06 million11/2/2023Q3 2023($0.47)($0.37)+$0.10($0.37)$1.75 million$0.31 million8/8/2023Q2 2023$0.55$0.36($0.19)$0.36$125.67 million$126.50 million 5/9/2023Q1 2023($0.57)($0.57)-($0.57)$1.58 million($0.52) million 3/7/2023Q4 2022($0.41)($0.54)($0.13)($0.54)$9.04 million$0.98 million11/2/2022Q3 2022($0.45)($0.49)($0.04)($0.49)$12.29 million$3.44 million Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($0.58)($0.70)($0.12)($0.70)$6.03 million$1.22 million5/4/2022Q1 2022($0.56)($0.61)($0.05)($0.61)$7.11 million$1.49 million 3/1/2022Q4 2021($0.45)($0.55)($0.10)($0.55)$19.48 million$7.22 million 11/10/2021Q3 2021($0.47)$0.72+$1.19$0.72$7.12 million$126.73 million 8/3/2021Q2 2021($0.41)($0.53)($0.12)($0.53)$4.40 million$5.26 million 5/4/2021Q1 2021($0.33)($0.39)($0.06)($0.39)$5.30 million$5.72 million Seres Therapeutics Earnings - Frequently Asked Questions When is Seres Therapeutics's earnings date? Seres Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on MCRB's earnings history. Did Seres Therapeutics beat their earnings estimates last quarter? In the previous quarter, Seres Therapeutics (NASDAQ:MCRB) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.08. Learn more on analysts' earnings estimate vs. MCRB's actual earnings. How much revenue does Seres Therapeutics generate each year? Seres Therapeutics (NASDAQ:MCRB) has a recorded annual revenue of $126.32 million. How much profit does Seres Therapeutics generate each year? Seres Therapeutics (NASDAQ:MCRB) has a recorded net income of -$113.72 million. MCRB has generated -$0.90 earnings per share over the last four quarters. What is Seres Therapeutics's EPS forecast for next year? Seres Therapeutics's earnings are expected to grow from ($1.15) per share to ($0.84) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cyteir Therapeutics Earnings Results Allakos Earnings Results Oramed Pharmaceuticals Earnings Results Celularity Earnings Results IO Biotech Earnings Results Anixa Biosciences Earnings Results DiaMedica Therapeutics Earnings Results Reviva Pharmaceuticals Earnings Results Rezolute Earnings Results Immunic Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings call This page (NASDAQ:MCRB) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.